Trial Profile
Open-label phase IIa trial of CYT 003 QbG10 monotherapy in patients with mild to moderate seasonal allergic rhinitis due to grass pollen allergy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2008
Price :
$35
*
At a glance
- Drugs Vidutolimod (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Cytos Biotechnology
- 14 Jun 2006 New trial record.